The article emphasizes the challenges in transitioning from lab findings to clinical applications, stressing the need for further research to optimize nanocarriers for cancer therapy. It explores the potential of nanocarriers and compounds for selective tumor targeting, including liposomes, nanoparticles, and micelles, focusing on those that have undergone clinical trials or have been approved for clinical use!
Progressing nanotechnology to improve... - Advanced Prostate...
Progressing nanotechnology to improve targeted cancer treatment: not related to prostate cancer only
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Nano? Not my Nano. What's Grandpa got to do with this stuff......Wait till I tell Nana, she's gonna be mad...........
Good Luck, Good Health and Good Humor.
j-o-h-n Sunday 12/03/2023 6:30 PM EST
Not what you're looking for?
You may also like...
Progressing metastatic prostate cancer
5. Never have had physical symptoms but have undergone neoadjuvant hormone ablation, prostatectomy...
Study reports direct targets of ivermectin in prostate cancer
have been identified, few studies have focused on the exact target of ivermectin. Herein, we report...
nanoparticles prostate cancer treatment?
com/articles/323875.php
This article is a bit anemic, it \\"tries\\" to explain Gold nanoparticles,...
Prostate Cancer Radiation treatments
so later this week I will begin a series of 48 focused radiation treatments at Sloan Kettering....
New prostate cancer treatment concept
Recent clinical trials have hinted that combining immunotherapy and radiation therapy may be a...